Target intelligence / Profile preview

ATP-binding cassette sub-family A member 12 (ABCA12)

Target
ABCA12
Molecular classification
Transporter, ATP-binding cassette (ABC) transporter, Lipid transporter
01

Overview

ATP-binding cassette sub-family A member 12 (ABCA12) is a transmembrane lipid transporter that is part of the ATP-binding cassette (ABC) transporter superfamily, specifically the ABC1 subfamily[1][2][3][4][7]. It is predominantly expressed in keratinocytes in the epidermis, where it transports glucosylceramides and ceramides into lamellar granules. This function is critical for forming the extracellular lipid layers of the stratum corneum and thereby maintaining the skin's barrier properties[1][2][3][4]. Mutations in ABCA12 cause severe inherited skin disorders such as harlequin ichthyosis and lamellar ichthyosis by disrupting epidermal lipid transport, leading to defective barrier formation and abnormal keratinization[1][2][3][5]. ABCA12 may also regulate cholesterol efflux, insulin secretion, and participate in surfactant biogenesis in other tissues[4][7]. At present, ABCA12 itself is not a direct drug target, but its loss-of-function mutations are significant biomarkers for genetic diagnosis and prognosis in ichthyosis syndromes.

Other names
Glucosylceramide transporter ABCA12ABC12ATP-binding cassette 12DKFZP434G232LI2ATP-binding cassette sub-family A member 12ATP-binding cassette transporter 12ARCI4AARCI4BICR2BATP-binding cassette, sub-family A (ABC1), member 12
02

Mechanism of action

Not applicable due to lack of known interacting drugs. In concept, therapeutic approaches could target enhancement or correction of defective lipid transport.

03

Biological functions

Lipid transportCellular membrane transportKeratinocyte differentiationSkin barrier formationProtease trafficking (desquamation regulation)Regulation of cholesterol homeostasisRegulation of insulin granule morphology and secretionSurfactant biogenesis
04

Disease associations

Congenital ichthyosis (including harlequin ichthyosis, lamellar ichthyosis type 2, congenital ichthyosiform erythroderma)Skin disorders affecting barrier functionPotentially involved in other barrier defects (lung, metabolic)
05

Safety considerations

Potential for severe skin barrier impairment if ABCA12 is inhibited or lost (would cause ichthyosis-like phenotypes and life-threatening barrier dysfunction)Intact lipid transport is essential for barrier tissues, so off-target effects could be severe if targeted incorrectly
06

Biomarkers

ABCA12 protein/mRNA expression (for diagnosis of congenital ichthyosis subtypes)Glucosylceramide distribution in keratinocytes (disease correlation)

Beyond the preview

Go deeper on ATP-binding cassette sub-family A member 12 (ABCA12).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on ATP-binding cassette sub-family A member 12 (ABCA12).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call